Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPLZL.L Regulatory News (PLZL)

  • There is currently no data for PLZL

Rule 8.1- OJSC Polyus Gold

17 Jul 2009 09:55

RNS Number : 8562V
Renaissance Capital Limited
17 July 2009
Β 

ο»Ώ

Β  FORM 8.1

DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES

FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

(RulesΒ 8.1(a) and (b)(i)Β ofΒ theΒ TakeoverΒ Code)

1. KEY INFORMATION

Name of person dealingΒ (Note 1)

Subsidiaries of Renaissance Capital Holdings Limited trading under theΒ Renaissance CapitalΒ brand

Company dealt in

OJSC Polyus Gold

Class of relevant security to which the dealings being disclosed relateΒ (NoteΒ 2)

1 RUB ordinary (OJSC Polyus Gold)

Date of dealing

16Β JulyΒ 2009

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) InterestsΒ and short positionsΒ (following dealing) in the class of relevant security dealt inΒ (Note 3)

Long

Short

Number (%)

Number (%)

(1) Relevant securitiesΒ 

246,379 (0.12%)

224,406 (0.12%)

(2) Derivatives (other than options)

1,240,000 (0.65%)

(3) Options and agreements to purchase/sell

Total

Β 246,379 (0.12%)

1,494,406 (0.78%)

(b) InterestsΒ and short positionsΒ in relevant securities of the company, other than theΒ classΒ dealt inΒ (Note 3)

Class of relevant security:

Long

Short

Number (%)

Number (%)

(1) Relevant securitiesΒ 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

(c) Rights to subscribeΒ (Note 3)

Class of relevant security:

Details

3. DEALINGSΒ (Note 4)

(a) Purchases and sales

Total number of securities purchased

Highest price paidΒ (Note 3)

Lowest price paidΒ (Note 3)

1,511Β ordinary shares

17,000Β ordinary shares

14,600Β ADRs (conversion ratio 1 ADR:0.5 share)

USDΒ 36.544

RURΒ 1174.893

USDΒ 19.900

USDΒ 35.461

RURΒ 886.872

USDΒ 19.701

Total number of securities sold

Highest price receivedΒ (Note 3)

Lowest price receivedΒ (Note 3)

500Β ordinary shares

18,332Β ordinary shares

14,600Β ADRs (conversion ratio 1 ADR:0.5 share)

USDΒ 36.662

RURΒ 1171.125

USDΒ 19.896

USDΒ 36.358

RURΒ 886.872

USDΒ 19.726

(b) Derivatives transactions (other than options)

Product name,Β 

e.g. CFD

Long/shortΒ (Note 6)

Number of securitiesΒ (Note 7)

Price per unitΒ (Note 5)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g.Β callΒ option

Writing, selling, purchasing, varying etc.

Number of securitiesΒ to which the option relatesΒ (Note 7)

Exercise

priceΒ 

Type,Β e.g. American, European etc.

ExpiryΒ 

date

Option money

paid/receivedΒ per unitΒ (Note 5)

(ii) Exercising

Product name,Β e.g.Β call option

Number of securitiesΒ 

Exercise priceΒ per unitΒ (Note 5)

(d) Other dealings (including new securities)Β (Note 4)

Nature of transactionΒ (Note 8)

Details

PriceΒ per unitΒ (if applicable)Β (Note 5)Β 

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingΒ toΒ the voting rights of any relevant securities under any option referred to on this form orΒ relating to the voting rights orΒ future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached?Β (Note 9) YES

Date of disclosure

17Β JulyΒ 2009

Contact name

Bridget Andrews

Telephone number

020 7367 7988

Name of offeree/offerorΒ with whichΒ associated

Jenington International Inc (an indirect wholly owned subsidiary of OJSC Polyus Gold)Β 

Specify category and nature of associate statusΒ (Note 10)

Acting in concertΒ as a result of a 50%Β less one-half of one shareΒ ownership of Renaissance Financial Holdings Limited by ONEXIM Group.

Notes

TheΒ NotesΒ onΒ Form 8.1 can be viewed on the Takeover Panel's website atΒ www.thetakeoverpanel.org.uk

SUPPLEMENTAL FORM 8

DETAILS OF OPENΒ POSITIONSΒ 

(This form should be attached to Form 8.1, Form 8.1(b)(ii)Β or Form 8.3, as appropriate)

OPENΒ POSITIONSΒ (NoteΒ 1)

Product name,

e.g.Β call option

Written or purchased

Number of securitiesΒ to which the option or derivative relates

Exercise priceΒ (Note 2)

Type, e.g. American, European etc.

Expiry date

Β Total return swap

Written

1,750,000 ADRs

Market price at termination date

Traders agreed on securities settlement - confirmation stated cash settled

24 November 2009

Total return swap

Written

730,000 ADRs

Market price at termination date

Traders agreed on securities settlement - confirmation stated cash settled

17 July 2009

Notes

1.Β Where there are open option positions or open derivative positions (except for CFDs), full details should be given.Β Β Full details of anyΒ Β existing agreements to purchase or to sellΒ Β shouldΒ also be given on this form.Β Β 

2. For all prices and other monetary amounts, the currency must be stated.

For details of the Code's dealing disclosure requirements, see Rule 8 and its Notes which can be viewed on the Takeover Panel's website atΒ www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DCCVDLBFKDBEBBL
Date   Source Headline
7th Jun 20223:41 pmRNSEGM results
13th May 20226:00 pmRNSChanges in shareholder structure
13th May 20222:35 pmRNSUpdate on LSE listing
12th May 20221:08 pmRNSNominations to the interim Board of Directors
29th Apr 20225:25 pmRNSAnnual Review
25th Apr 20222:26 pmRNSUpdate on operational and financial results
14th Apr 20221:14 pmEQSPOLYUS PJSC: Notice of EGM
11th Apr 20224:05 pmRNSChanges in senior management
6th Apr 202212:31 pmRNSChanges in shareholder structure
4th Apr 202211:40 amRNSFitch withdraws Polyus Finance Plc credit rating
4th Apr 202211:30 amRNSFitch withdraws PJSC Polyus credit rating
1st Apr 20225:11 pmRNSS&P lowers and withdraws Polyus credit rating
31st Mar 20224:45 pmRNSMoody’s withdraws Polyus Finance Plc credit rating
31st Mar 20224:29 pmRNSMoody’s withdraws PJSC Polyus credit rating
30th Mar 20221:03 pmRNSRepayment of Eurobond due 28 March 2022
23rd Mar 20224:31 pmRNSCorporate Update
23rd Mar 20224:23 pmRNSDirector/PDMR Shareholding
14th Mar 202212:49 pmRNSFitch downgrades PJSC Polyus rating
11th Mar 202211:34 amRNSMoody’s downgrades PJSC Polyus rating
9th Mar 20223:43 pmRNSChanges to the Board of Directors
9th Mar 20222:26 pmRNSConference call cancellation - replacement
9th Mar 20221:14 pmRNSS&P downgrades PJSC Polyus rating
7th Mar 20227:00 amRNSMSCI ESG Rating downgrades PJSC Polyus rating
7th Mar 20227:00 amRNSFitch downgrades PJSC Polyus rating to ‘B’
4th Mar 20223:37 pmRNSPJSC Polyus reports acquisition of shares
2nd Mar 20224:36 pmRNSPrice Monitoring Extension
2nd Mar 20222:09 pmRNSDirector/PDMR Shareholding
1st Mar 20224:43 pmRNSSecond Price Monitoring Extn
1st Mar 20224:38 pmRNSPrice Monitoring Extension
1st Mar 20227:00 amRNSFinancial results for 4Q and full year 2021
28th Feb 202210:54 amRNSNotice of Results – replacement
25th Feb 20222:37 pmRNSNotice of financial results for 4Q and 2021
8th Feb 20227:00 amRNSTrading update for 4Q 2021 and full year 2021
31st Jan 20224:51 pmRNSAnnounces launch of a buyback programme
30th Dec 20212:29 pmRNSDirector/PDMR Shareholding
23rd Nov 20217:00 amRNSFinancial results for the third quarter of 2021
18th Nov 20219:59 amRNSESG ratings and rankings update
17th Nov 202111:45 amRNSNotice of 3Q 2021 financial results
28th Oct 20214:00 pmRNSDirector/PDMR Shareholding
28th Oct 20217:00 amRNSTrading update for the third quarter of 2021
22nd Oct 20214:38 pmRNSDirector/PDMR Shareholding
14th Oct 20214:18 pmRNSClosing of USD 700 million Eurobonds offering
14th Oct 20214:03 pmRNSClosing of USD 700 million Eurobonds offering
8th Oct 202111:40 amRNSExpert RA raises Polyus credit rating to ‘ruAAA’
8th Oct 20218:28 amRNSResults of the capped tender offer
8th Oct 20218:19 amRNSResults of the capped tender offer
7th Oct 20219:12 amRNSINDICATIVE RESULTS OF THE CAPPED TENDER OFFER
7th Oct 20219:02 amRNSINDICATIVE RESULTS OF THE CAPPED TENDER OFFER
30th Sep 20212:12 pmRNSEGM results
28th Sep 202112:29 pmRNSTender offer for notes due 2022, 2023 and 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.